Related Experiment Video

Updated: Jul 14, 2026

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

Disease severity in patients with simultaneous influenza and bacterial pneumonia

Masafumi Seki1, Kosuke Kosai, Katsunori Yanagihara

  • 1Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences. seki@nagasaki-u.ac.jp

Internal Medicine (Tokyo, Japan)
|July 3, 2007
PubMed
Abstract

Insights

Influenza virus co-infection significantly worsens bacterial pneumonia severity, increasing complications and inflammatory markers. This suggests influenza enhances bacterial pneumonia, necessitating further research into their interaction.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Virology

Background:

  • Bacterial pneumonia is a common respiratory illness.
  • Influenza virus infections can predispose individuals to secondary bacterial infections.
  • The synergistic effects of co-infection on clinical presentation require clarification.

Purpose of the Study:

  • To compare clinical features of bacterial pneumonia patients with and without concurrent influenza virus infection.
  • To identify differences in disease severity and complications between co-infected and non-co-infected groups.

Main Methods:

  • Retrospective comparison of adult patients with bacterial pneumonia.
  • Group 1: Co-infected with influenza virus (n=15).
  • Group 2: Bacterial pneumonia alone (n=28).

Main Results:

  • Co-infected patients showed higher rates of chronic lung disease complications.
  • Significant differences observed in body temperature and heart rate.
  • Elevated CRP levels, worse chest X-ray findings, and increased pneumonia severity (JRS/IDSA criteria) in co-infected patients.

Conclusions:

  • Influenza virus and bacterial co-infection leads to significantly more severe pneumonia than bacterial pneumonia alone.
  • Influenza virus infection appears to exacerbate bacterial pneumonia.
  • Further investigation into the pathogenesis of this synergistic interaction is warranted.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...